Carol-Anne Krech
Former Member
Thumbnail Image
Last Name
Krech
First name
Carol-Anne
Phone
+41 71 224 7228

Filters

5 3
Reset filters

Settings
Now showing 1 - 8 of 8
No Thumbnail Available
Publication

PROFITING FROM INVENTION: BUSINESS MODELS OF PATENT AGGREGATING COMPANIES

2015-06-01 , Krech, Carol Anne , Rüther, Frauke , Gassmann, Oliver

Patent aggregating companies are institutions that aggregate patents for different purposes. From a managerial perspective as well as a theoretical perspective, it is interesting to understand what value such novel business models provide to inventing companies. In this paper we focus on the question how patent holders can use patent aggregating companies as means to capture value from their inventions. Therefore the business models of patent aggregating companies need to be understood. Existing literature lacks a systematic and comprehensive analysis of the patent aggregating companies' business models. The empirical data presented and discussed in this article was collected over a five-year (2009-2014) period in semi-structured interviews with patent aggregating companies' incorporating personnel and in an extensive analysis of secondary data. We conclude our study by identifying four groups of patent aggregating companies based on the values provided to the original patent holders: the guarders, the shielders, the funders and the earners.

View
No Thumbnail Available
Publication

Out-Licensing in Pharmaceutical Research and Development

2016 , Gassmann, Oliver , Krech, Carol Anne , Martin A. Bader , Gerrit Reepmeyer , Alexander Schuhmacher , Markus Hinder , Oliver Gassmann

Seventy percent of pharmaceutical companies expect their collaborations will primarily take the traditional forms of out-licensing products or technology. Whereas research alliances, in-licensing, and co-development are quite established and traditional collaboration approaches, many established pharmaceutical companies have long considered out-licensing a difficult task. The purpose of this chapter is to illustrate how out-licensing by pharmaceutical companies can contribute to an increase in research and development (R&D) efficiency. A case study of Novartis demonstrates how the out-licensing can be successfully adopted and managed. Successfully executed out-licensing programs provide pharmaceutical firms with several benefits such as additional revenue generation, cost- and resource effectiveness, and mitigation of R&D related risks.

View
No Thumbnail Available
Publication

Value creation approaches used in Open Innovation: an intellectual property view

2019 , Krech, Carol-Anne

View
No Thumbnail Available
Publication

Markets for technology: How an organized patent market can improve technology transfer

2015-04-16 , Krech, Carol Anne , Bader, Martin A. , Liegler, Florian , Gassmann, Oliver

Patent trade has attracted increasing attention from practitioners as patents gain in importance as a means to technology trading. However, this topic is still widely neglected in the academic literature. A market is required for trade to occur. The better a market is organized, the more likely demands and offers will be met. We found that no organized market for patents has yet evolved. Because the structuring of this market may contribute to economic growth and the achievement of technology policy goals, we develop the framework for an organized patent market. The empirical data presented and discussed was collected by semi-structured interviews among 58 experts in the field of intellectual property rights and secondary data analysis. We identified limitations in the current patent market that can be addressed by the concept of an organized patent market consisting of the Patent Asset Market and the Patent Financial Market. We found that an organized patent market creates value by enhancing market transparency, improving resource allocation, and providing an additional source of innovation funding

View
No Thumbnail Available
Publication

Open platforms for strategic technologies (“Plataformas Abiertas para Tecnologías Estratégicas”)

2014 , Bader, Martin A. , Gassmann, Oliver , Krech, Carol-Anne

View
No Thumbnail Available
Publication

How Patent Assertion Entities Search for their Prey – An Attention-based View

2019 , Krech, Carol-Anne , Lingens, Bernhard , Gassmann, Oliver

View
No Thumbnail Available
Publication

Business Models of Patent Aggregating Companies

2014-12-07 , Krech, Carol Anne , Rüther, Frauke , Gassmann, Oliver

Decorated with the Knut Holt Best Paper Award

View
No Thumbnail Available
Publication

Integrated Innovation and Patent Management: A Capability Perspective

2019 , Krech, Carol-Anne

View